Old Web
English
Sign In
Acemap
>
Paper
>
534P Larotrectinib in non-CNS TRK fusion cancer patients: Outcomes by prior therapy and performance status
534P Larotrectinib in non-CNS TRK fusion cancer patients: Outcomes by prior therapy and performance status
2021
A. Drilon
Li Shen
C.M. van Tilburg
D.S.W. Tan
Shivaani Kummar
Jessica J. Lin
François P Doz
Raymond S. McDermott
Catherine M. Albert
Jordan Berlin
Stefan S. Bielack
Ulrik Lassen
Makoto Tahara
Ricarda Norenberg
Marc Mardoche Fellous
Hendrik Nogai
R. Xu
Theodore W. Laetsch
David S. Hong
Keywords:
Prior Therapy
Trk receptor
Oncology
Cancer
Performance status
Medicine
Internal medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]